Bio-Technology General (BTG) is the leading fully integrated biopharmaceutical services company in Israel and the region. Established in 1980, our company has a proud and pioneering tradition in the biotech arena. As a wholly-owned subsidiary of Ferring Pharmaceuticals since 2005, BTG is proud to play a vital role in Ferring’s expanding global manufacturing and development activities. Engaged in the development and manufacture of human health care products derived from genetic engineering and biotechnology processes, we also offer a wide range of well integrated CMO-type services and activities.
Our therapeutic products, developed and manufactured in-house, are registered and sold in more than 45 countries worldwide, including the United States, Europe, Japan and countries in Asia and Latin America, through Ferring and Ferring resellers. Our contract services are based on years of experience and expertise in developing recombinant products based on microbial fermentation, mammalian cell culture and biopharmaceutical processes.
The BTG family has expanded over the years and today boasts a staff of nearly 300 employees, working in its state-of-the-art 10,000 square meter cGMP manufacturing facility and 1,700 square meter development wing that includes laboratories and pilot plants in central Israel. These facilities are approved by both local and international regulatory quality control authorities.